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CASE REPORT
Successful cutting balloon angioplasty 
in a child with resistant renal artery stenosis
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Abstract 
Background: Although renovascular hypertension is a rare disease, it is associated with 5–10 % of cases of childhood 
hypertension. It is a potentially treatable cause of hypertension, and is often caused by renal artery stenosis (RAS). The 
most common cause of RAS in children is fibromuscular dysplasia (FMD). The options for treating RAS depend on the 
location, severity and abnormality underlying the condition.
Case presentation: A previously healthy 7-year-old Korean boy presented to our clinic with hypertension and 
headache. Renal ultrasonography and multi-detector computed tomography (MDCT) showed severe focal stenosis at 
the middle portion of the left renal artery (LRA) and multiple collateral vessels. Percutaneous balloon angioplasty was 
performed as an initial treatment, but yielded unsatisfactory results. The presence of intimal-type FMD was suspected 
based on his clinical features, angiographic appearance, and resistance to percutaneous transluminal renal angio-
plasty. Thereafter, his blood pressure was normalized using antihypertensive medication. Follow-up multi-detector 
computed tomography at 11 years of age showed persistent severe stenosis of the LRA. After unsuccessful attempts 
to perform balloon angioplasty, 3.5-mm cutting balloon angioplasty (CBA) was performed and yielded satisfactory 
results. He was discharged without any medication. At 1 year and 6 months after the intervention, he has been nor-
motensive and had not required any antihypertensive medication.
Conclusion: The author describes a case of resistant RAS that was detected on MDCT and successfully treated using 
percutaneous (CBA). Although cutting balloon angioplasty is useful in many clinical conditions, including the current 
case, clinicians should carefully consider the associated risk of arterial disruption and pseudoaneurysm formation.
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Background
Although renovascular hypertension (RVH) is a rare dis-
ease, it is an important cause of childhood hypertension, 
and serves as a causative factor in 5–10  % of all cases 
of childhood hypertension [1]. It is a potentially treat-
able cause of hypertension, and is often caused by renal 
artery stenosis (RAS); however, it is difficult to diagnose 
and treat in children. Conventional contrast angiography 
(CCA) remains the gold standard for the evaluation of 
the renal artery, but multi-detector computed tomogra-
phy (MDCT) also enables to provide anatomical evalu-
ation at a high resolution with a short scan time [2, 3]. 
The most common cause of RAS in children is fibromus-
cular dysplasia (FMD); this can be treated by percutane-
ous transluminal renal angioplasty (PTRA), with a high 
technical and clinical success rate [4]. As PTRA is less 
invasive and more cost-effective alternative to open sur-
gery and can be performed with a high degree of tech-
nical success with minimal complications, PTRA with a 
conventional balloon catheter has become the primary 
choice for revascularization, particularly in cases caused 
by FMD. However, some lesions are resistant to PTRA 
with conventional balloons and typically require open 
surgery. Following technical advancements, cutting bal-
loon angioplasty (CBA) was recently introduced, and 
may serve as a useful treatment option for RAS resistant 
to PTRA with conventional balloons in children. A con-
ventional balloon tears the stenotic arterial wall, whereas 
the cutting balloon—which has 3–4 longitudinal blades 
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mounted on the outer surface—creates an incision in the 
vessel wall with these blades, reduces elastic recoil, and 
can improve the technical result and possibly long-term 
patency [2, 5]. In the present report, the author describes 
a case of resistant RAS that was suspected to be caused 
by FMD, was confirmed by MDCT, and was successfully 
treated with CBA.
Case presentation
A previously healthy 7-year-old Korean boy presented 
to our clinic with hypertension and intermittent head-
aches. His blood pressure (BP) was 137/93  mmHg and 
24  h ambulatory mean BP was 181/117  mmHg (day-
time, 197/125 mmHg; nighttime, 160/91 mmHg). He was 
admitted for further evaluation of the hypertension. He 
had no episodes of persistent fever of unknown origin, 
and no symptoms such as stomatitis, arthritis, and skin 
rash that were indicative of autoimmune disease. There 
was no family history for autoimmune, cardiovascular, or 
renal disease. Except for the high BP values, the physical 
examination yielded unremarkable results. He also didn’t 
exhibit any facial anomalies or skin lesions. Laboratory 
examination indicated that blood cell count, serum cre-
atinine levels, serum electrolyte levels, thyroid function, 
and urinalysis results were normal. In addition, serum 
C-reactive protein (CRP) levels and erythrocyte sedi-
mentation rate (ESR) were normal. Vasculitis screening, 
including tests for antinuclear antibodies, antibodies to 
double-stranded DNA, and anti-neutrophil cytoplas-
mic antibodies, indicated normal results. Fundoscopic 
examination showed minimally increased vascular tor-
tuosity. Echocardiography showed no specific abnor-
malities. Renal ultrasonography demonstrated abnormal 
Doppler waveforms in the left kidney, characterized 
by a tardus–parvus pattern [6]. A 64-channel MDCT 
showed severe focal stenosis at the middle portion of the 
left renal artery (LRA) and multiple collateral vessels. 
PTRA was performed with multiple inflations; during 
the final attempt, the balloon was inflated at a pressure 
beyond the burst pressure. However, unsatisfactory 
results were obtained. The author suspected a diagnosis 
of intimal-type FMD based on his clinical features, angio-
graphic appearance, and resistance to PTRA. As his BP 
could be well controlled with antihypertensive medica-
tion after the initial intervention, the author decided to 
attempt PTRA once more or another surgery after he 
reached puberty. A repeat MDCT (Fig. 1a) at 11 years of 
age showed persistent severe stenosis at the middle por-
tion of the LRA with post-stenotic dilatation. Abdomi-
nal angiography (Fig.  2a) showed similar results, and 
hence, PTRA was attempted 3 times by using high pres-
sure balloons with different sizes. However, as the dila-
tation was not successful and the levels of inflammatory 
markers (ESR and CRP) were within normal range, we 
decided to attempt percutaneous revascularization via 
CBA. After CBA was performed with a 3.5-mm cutting 
balloon (Fig. 2b), repeat abdominal angiography (Fig. 2c) 
showed no clinically significant residual stenosis. He was 
discharged without any antihypertensive medication. At 
7 months after CBA, on follow-up MDCT, no signs of re-
stenosis of the LRA were noted (Fig. 1b). Subsequently, at 
1 year and 6 months after CBA, he appears normotensive 
and has not required any antihypertensive medication.
Discussion
RVH remains a diagnostic and therapeutic challenge in 
the pediatric population [7]. Various diseases, includ-
ing FMD, developmental RAS, neurofibromatosis type 1 
Fig. 1 Three-dimensional multi-detector computed tomographic angiogram. a Severe focal stenosis is observed in the proximal area of the left 
renal artery on pre-mapping with 64-channel multi-detector computed tomographic angiography, before the interventional procedure. b Dilated 
and patent renal artery stenosis is observed at 7 months after cutting balloon angioplasty
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(NF-1), Moyamoya disease, vasculitis such as Takayasu’s 
disease, Alagille syndrome, Marfan syndrome, and Wil-
liams syndrome, are associated with pediatric RVH [1, 
8]. FMD is an idiopathic angiopathy characterized by 
non-atherosclerotic and non-inflammatory fibroplastic 
disease that most commonly affects the renal and carotid 
arteries, and is the most common cause of pediatric 
RAS [9, 10]. In general, it is four times more prevalent in 
females than in males in adults, although the sex distri-
bution in children is equal [8]. FMD may be histologically 
classified based on the arterial wall layer involved—i.e., 
medial (70  % of cases), perimedial (15–25  %), and inti-
mal fibrodysplasias (1–2  %) [11]. The intimal type of 
FMD usually presents with a highly stenotic, usually 
proximal, localized lesion with post-stenotic dilatation. 
Angiographic features of the intimal type of FMS are 
more commonly noted on angiography in children than 
in adults. Both the medial and perimedial types of FMD 
manifest as alternating stenosis and aneurysms, such that 
they appear as a “string of beads” on angiography. How-
ever, this classic “string of beads” pattern is not frequently 
observed on angiography in children [1, 2, 8]. As FMD is 
often a suspected diagnosis or diagnosed based on exclu-
sion, the distinct clinical features between children and 
adults should be clearly determined. In particular, the 
medial type of FMD is less commonly encountered in 
children. In contrast, the intimal type of FMD is uncom-
mon in adults, but is the most common type in children 
[9]. Among the three histologic types of FMD, dilation is 
reported to be more difficult in the intimal type than in 
the medial or perimedial types. FMD is diagnosed based 
on the angiographic appearance and following the exclu-
sion of other conditions. In the present case, although 
the patient could not be diagnosed based on the results 
of histological examinations, we suspected a diagno-
sis of intimal-type FMD, based on the patients’ history, 
laboratory results, angiographic appearance (focal ste-
nosis in the middle of the renal artery with poststenotic 
dilatation, and no characteristic beaded pattern), and 
resistance to PTRA. Although the technical success rate 
of pediatric PTRA is high, the long-term success rate of 
pediatric PTRA is lower than that in adult; this difference 
may be due to the presence of a smaller vessel diameter 
and a more pronounced response to growth factors in 
immature vasculature [10]. Several imaging modalities 
such as CCA, Doppler ultrasonography, renal scintig-
raphy, computed tomography angiography (CTA), and 
magnetic resonance angiography (MRA) have been used 
to evaluate the renal artery. CCA is the gold standard for 
the diagnosis of RAS and is especially useful in the evalu-
ation of branch vessel disease. However, CCA requires 
arterial catheterization and the use of general anesthesia 
in young children, and is associated with a small risk of 
complications. CTA is a non-invasive technique that does 
not require arterial contrast injection, and reportedly has 
equivalent accuracy as that of MRA in adult patients [3]. 
MDCT can provide more detailed information for the 
three-dimensional visualization of RAS, with a shorter 
scan time, less respiratory motion artifacts, and high res-
olution, in a non-invasive manner [3]; moreover, the asso-
ciated cost and ionizing radiation exposure is lower than 
those associated with CCA [3, 12]. This could facilitate 
the planning of the interventional procedure, and may 
shorten the catheterization time and reduce the contrast 
injection dose required. Due to these advantages, CTA is 
currently used for pre-mapping, before the interventional 
procedure, in some centers [8]. The current day-to-day 
medical practice guidelines recommend that FMD should 
Fig. 2 Abdominal angiogram before and after cutting balloon angioplasty. a Abdominal aortogram shows a severe focal stenosis with post-sten-
otic dilatation in the proximal area of the left renal artery (arrow). b A 3.5-mm cutting angioplasty balloon is inflated, an incision is made successfully, 
and the stenotic region is dilated. c Abdominal aortogram shows a successfully dilated, patent left renal artery after cutting balloon angioplasty 
(arrow)
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be diagnosed based on the CTA or MRA findings. FMD 
may also be diagnosed using CCA (the gold standard), in 
cases where FMD is strongly suspected but the non-inva-
sive test results are inconsistent. During follow-up peri-
ods, CTA may also be useful to evaluate the effect of the 
therapies [13]. At present, PTRA is considered the treat-
ment of choice for RAS as a result of FMD, and has a high 
technical and clinical success rate [4, 7]. The treatment of 
RAS with PTRA may be difficult because of arterial wall 
thinning, friability, and the firm elastic recoil of the intra-
mural lesion in some conditions such as NF-1, William 
syndrome, or mid-aortic syndrome. In few cases, PTRA 
may not be able to dilate the RAS, and hence, the suc-
cess rates may vary from 48 to 90 % [7, 9, 14]. Even if it is 
not curative, PTRA may play a role in temporarily man-
aging hypertension in younger children prior to surgical 
repair scheduled during puberty. In the present case, as 
the hypertension was well controlled with anti-hyperten-
sive medication after initial PTRA, the decision to per-
form either re-intervention or open surgery was delayed 
until puberty, when the procedure can be performed 
with better long-term results, even though the result of 
initial PTRA was unsatisfactory. CBA is reportedly effec-
tive for treating stenotic lesions related to FMD that are 
resistant to conventional balloon angioplasty, particularly 
in cases of stenosis related to intimal FMD [2]. At pre-
sent, cutting balloons are available in a wide variety of 
diameters and lengths, with a range suitable for the treat-
ment of pediatric lesions, and have improved the techni-
cal success rate of PTRA. The complications associated 
with CBA in the treatment of RAS are similar to those for 
PTRA, including dissection, rupture, and thrombosis of 
the renal artery [15]. Although CBA extends the thera-
peutic potential for resistant RAS to small children, it is 
not a panacea and clinicians should not expect successful 
results in all children.
Conclusion
FMD is the most common cause of RAS in children. 
PTRA is a well-established therapy for RAS in adults and 
children, but conventional balloon angioplasty is ineffec-
tive in some patients. CBA is a safe and effective alterna-
tive to surgical therapy for resistant RAS. Although CBA 
is useful for the treatment of many clinical conditions, 
clinicians should not consider it an absolute treatment 
option and should not expect success in all children, as 
the efficacy and long-term effects of this procedure have 
not yet been established.
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